Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Choose more journals

Article type Check one or more article types to show results from those article types only.
Subject Check one or more subjects to show results from those subjects only.
Date Choose a date option to show results from those dates only.

Custom date range

Clear all filters
Sort by:
Showing 1–9 of 9 results
Advanced filters: Author: Giuseppe Deganutti Clear advanced filters

  • The glucagon-like peptide-1 receptor (GLP-1R) can be targeted in the treatment of diabetes, obesity and other metabolic disorders. Here, the authors assess the molecular mechanisms of peptide agonists binding to GLP-1R and the responses elucidated by these ligands, including distinct kinetics of G protein activation.

    • Giuseppe Deganutti
    • Yi-Lynn Liang
    • Denise Wootten
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-18

  • Wall et al. describe the selective activation of an adenosine A1 receptor-mediated intracellular pathway that provides potent analgesia in the absence of sedation or cardiorespiratory depression, paving the way for novel medicines based on the far-reaching concept of selective Gα agonism.

    • Mark J. Wall
    • Emily Hill
    • Bruno G. Frenguelli
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-22

  • The structure of GLP-1R and its G protein in complex with the small molecule TT-OAD2 sheds light on how the TT-OAD2 agonist can activate the receptor and provides insights into the development of therapeutic agents for metabolic disorders.

    • Peishen Zhao
    • Yi-Lynn Liang
    • Denise Wootten
    Research
    Nature
    Volume: 577, P: 432-436

  • The class B secretin GPCR (SecR) has broad physiological effects, with target potential for treatment of metabolic and cardiovascular disease. Here, authors present a cryo-EM structure and biochemical studies of secretin binding to the SecR:Gs complex which show that interactions between peptide and receptor were dynamic.

    • Maoqing Dong
    • Giuseppe Deganutti
    • Laurence J. Miller
    ResearchOpen Access
    Nature Communications
    Volume: 11, P: 1-17

  • Cagrilintide is a long-acting agonist of amylin and calcitonin receptors in late phase trials for obesity. Here, authors present structures of cagilintide with each target receptor, revealing the molecular basis for its non-selective action.

    • Jianjun Cao
    • Matthew J. Belousoff
    • Patrick M. Sexton
    ResearchOpen Access
    Nature Communications
    Volume: 16, P: 1-15

  • The structure of a complex containing calcitonin gene-related peptide, the human calcitonin gene-related peptide receptor and the Gs heterotrimer, determined using Volta phase-plate cryo-electron microscopy, provides structural insight into the regulation of G-protein-coupled receptors by receptor activity modifying protein 1.

    • Yi-Lynn Liang
    • Maryam Khoshouei
    • Patrick M. Sexton
    Research
    Nature
    Volume: 561, P: 492-497

  • Previously, peptide selectivity in the VPAC receptor family of GPCRs was poorly understood. Here, authors combine cryo-EM and MD data to understand binding and selectivity of VPAC1R and PAC1R peptide agonists that can guide future drug development.

    • Sarah J. Piper
    • Giuseppe Deganutti
    • Denise Wootten
    ResearchOpen Access
    Nature Communications
    Volume: 13, P: 1-20